OUP Management as of June 30, 2022
Portfolio Holdings for OUP Management
OUP Management holds 15 positions in its portfolio as reported in the June 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Centessa Pharmaceuticals Sponsored ADS (CNTA) | 19.7 | $14M | 2.9M | 4.87 | |
| PMV Pharmaceuticals Common Stock (PMVP) | 19.4 | $14M | 989k | 14.25 | |
| Aerovate Therapeutics Common Stock (AVTE) | 13.0 | $9.4M | 604k | 15.63 | |
| DICE Therapeutics Common Stock | 11.5 | $8.3M | 537k | 15.52 | |
| Cyteir Therapeutics Common Stock | 10.2 | $7.4M | 2.5M | 2.99 | |
| ionQ Common Stock (IONQ) | 8.3 | $6.0M | 1.4M | 4.38 | |
| Evolv Technologies Holdings Common Stock (EVLV) | 5.8 | $4.2M | 1.6M | 2.66 | |
| Vor Biopharma Common Stock (VOR) | 2.6 | $1.9M | 375k | 4.97 | |
| Precision BioSciences Common Stock | 2.5 | $1.8M | 1.1M | 1.60 | |
| eFFECTOR Therapeutics Common Stock | 2.0 | $1.5M | 1.0M | 1.42 | |
| Landos Biopharma Common Stock | 1.6 | $1.2M | 1.6M | 0.73 | |
| Selecta Biosciences Common Stock (RNAC) | 1.6 | $1.1M | 863k | 1.31 | |
| Graphite Bio Common Stock | 1.5 | $1.1M | 406k | 2.75 | |
| Spero Therapeutics Common Stock (SPRO) | 0.3 | $185k | 249k | 0.74 | |
| Homology Medicines Common Stock | 0.2 | $126k | 64k | 1.97 |
